CCR7 expression is highly expressed in patients with pancreatic cancer and is suggested to be positively associated with poor outcomes such as short survival, lymph node metastasis, lymphangiogenesis, and angiogenesis [41,44,45]. This evidence concerns the gene CCR7 and pancreatic neoplasm.